HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ramoplanin: a lipoglycodepsipeptide antibiotic.

AbstractOBJECTIVE:
To review the pharmacology, antimicrobial activity, pharmacokinetics, clinical applications, and safety of ramoplanin, a lipoglycodepsipeptide antibiotic.
DATA SOURCES:
Information was obtained from MEDLINE and BIOSIS databases (1984-August 2004) and Oscient Pharmaceuticals using the key words ramoplanin, A 16686, A 16686A, and MDL 62198.
STUDY SELECTION AND DATA EXTRACTION:
Available English-based articles and abstracts were reviewed, along with information from Oscient Pharmaceuticals.
DATA SYNTHESIS:
Ramoplanin exerts its bactericidal activity against gram-positive aerobic and anaerobic bacteria by blocking peptidoglycan synthesis via lipid II. In vitro susceptibility reports have demonstrated efficacy against antibiotic-resistant gram-positive pathogens. Cross-resistance has not been documented with vancomyin and other glycopeptides. Clinical trials are investigating ramoplanin's oral administration for treatment of Clostridium difficile-associated diarrhea. Previous clinical trials had evaluated the suppression of colonization of vancomycin-resistant Enterococcus with ramoplanin. Adverse effects are minimal, and drug-drug interactions have not been documented.
CONCLUSIONS:
The completion of clinical trials will determine whether ramoplanin has a promising role as a treatment option for diarrhea due to C. difficile.
AuthorsDebra K Farver, Dennis D Hedge, Steven C Lee
JournalThe Annals of pharmacotherapy (Ann Pharmacother) Vol. 39 Issue 5 Pg. 863-8 (May 2005) ISSN: 1060-0280 [Print] United States
PMID15784805 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Bacterial Agents
  • Depsipeptides
  • ramoplanin
Topics
  • Adult
  • Anti-Bacterial Agents (adverse effects, pharmacokinetics, therapeutic use)
  • Clinical Trials as Topic
  • Clostridioides difficile (drug effects, pathogenicity)
  • Depsipeptides (adverse effects, pharmacokinetics, therapeutic use)
  • Diarrhea (drug therapy)
  • Humans
  • Microbial Sensitivity Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: